0001179110-20-006750.txt : 20200601
0001179110-20-006750.hdr.sgml : 20200601
20200601161513
ACCESSION NUMBER: 0001179110-20-006750
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200528
FILED AS OF DATE: 20200601
DATE AS OF CHANGE: 20200601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Mark Douglas
CENTRAL INDEX KEY: 0001756253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 20933563
MAIL ADDRESS:
STREET 1: C/O TELADOC HEALTH, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2020-05-28
0
0001477449
Teladoc Health, Inc.
TDOC
0001756253
Smith Mark Douglas
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
0
0
0
Restricted Stock Units
2020-05-28
4
M
0
3012
A
3012
D
Restricted Stock Units
2020-05-28
4
M
0
3012
0.00
D
Common Stock
3012
0
D
Restricted Stock Units
2020-05-28
4
A
0
1049
0.00
A
Common Stock
1049
1049
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
On May 30, 2019, the reporting person was granted 3,012 restricted stock units, vesting in full on May 28, 2020.
The restricted stock units vest in full on the earlier of (i) May 28, 2021 and (ii) the day immediately preceding the issuer's 2021 annual meeting of stockholders. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
/s/ Adam C. Vandervoort, attorney-in-fact
2020-06-01